For former shareholders of Kronos Bio Inc., the summer of 2027 represents a pivotal deadline. This date stems from the ...
In the preceding three months, 4 analysts have released ratings for Kronos Worldwide (NYSE:KRO), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results